1. Volume 138, Issue 1, Pages 6-12.e2 (January 2010)
HCV Research 20 Years After Discovery: A Summary of the 16th International Symposium on Hepatitis C Virus and Related Viruses 
Jean–Michel Pawlotsky, Laurence Cocquerel, David Durantel, Dimitri Lavillette, Hervé Lerat, Eve–Isabelle Pécheur, Stephen J. Polyak, Norbert Tautz, Robert Thimme 
Gastroenterology 
Volume 138, Issue 1, Pages 6-12.e2 (January 2010)
DOI: /j.gastro
Copyright © 2010 AGA Institute Terms and Conditions

2. Figure 1
Image from the video developed by the iCAP facilities at the University of Lyon 1 showing the HCV receptor interaction at the early phase of HCV entry. Reprinted with permission; contribution: François Penin and Eve-Isabelle Pécheur (available at
Gastroenterology  , 6-12.e2DOI: ( /j.gastro )
Copyright © 2010 AGA Institute Terms and Conditions

3. Figure 2
Targets for specific inhibitors of HCV life cycle. GAG, glycosaminoglycans; LDLR, low-density-lipoprotein receptor; SR-B1, scavenger receptor B1; CLDN1, claudin 1; OCLN, occludin; Abs, antibodies; miR122, microRNA 122; VLDL, very-low-density lipoprotein; CsA, cyclosporine; CypA, cyclophilin A; NI, nucleoside/nucleotide inhibitors; NNI, non-nucleoside inhibitor. Reprinted with permission; contribution: Shihyun You and Charles Rice.
Gastroenterology  , 6-12.e2DOI: ( /j.gastro )
Copyright © 2010 AGA Institute Terms and Conditions